The Asia-Pacific pharma industry experienced a 4% drop in new job postings in Q2 2023 compared with the previous quarter, with the highest share accounted for by Syngene International with 1,873 job postings, according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharmaceutical Drugs Development Annual Review provides a comprehensive analysis of the pharmaceutical industry in 2022, focusing on drug development trends, future opportunities and key movements in regulatory, clinical, and market aspects. Buy the report here.
Notably, Management Occupations jobs accounted for a 23% share of the Asia-Pacific pharma industry’s total new job postings in Q2 2023, drop 14% over the prior quarter.
Management Occupations drive pharma hiring activity
Management Occupations, with a share of 23% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q2 2023 , ahead of Computer and Mathematical Occupations with an 11% share of new job postings.
The other prominent roles included Healthcare Practitioners and Technical Occupations with a 7% share in Q2 2023, Business and Financial Operations Occupations with a 6% share and Life, Physical, and Social Science Occupations with a 6% share of new job postings.
Top five companies accounted for 43% of hiring activity
Syngene International posted 1,873 jobs in Q2 2023 and registered a decline of 69% over the previous quarter, followed by Novartis with 1,814 jobs and a 74% growth. AstraZeneca, with 1,479 jobs, and Pfizer, with 1,446 jobs, recorded a 118% rise and a 69% rise, respectively, while Biocon recorded a 48% decline with a 1,387 new job postings during Q2 2023.
Regional analysis of hiring in the Asia-Pacific pharma industry, Q2 2023
India held the leading share of the Asia-Pacific pharma hiring activity with a 49.83% share, a 23% decrease over Q1 2023. China was next with 26.76%, four-percentage-point up over the previous quarter.
For further understanding of GlobalData's Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis, buy the report here.